The Worldwide Autoinjectors Market to 2024: Breakdown by Product, Application and Region - ResearchAndMarkets.com

The "Autoinjectors Market Forecast up to 2024" report has been added to ResearchAndMarkets.com's offering.

The global autoinjectors market is estimated to witness a CAGR of 17.1% during the forecast period 2018-2024. The market is analyzed based on three segments - products, applications and regions.

Raising prevalence of serious medical conditions such as anaphylaxis & other food allergies, advancements in the autoinjectors technology, increasing demand for home healthcare, and the rising need for self-injectors are the factors aiding the growth of the autoinjectors market.

Novel formulations of drugs and advancements in drug delivery systems along with favorable government regulations are providing an opportunity for the market growth. However, recent product recalls by the companies and the availability of substitutes for autoinjectors are hampering the market growth.

Product Analysis: Based on the products, the market is segmented into disposable autoinjectors and reusable autoinjectors. Disposable autoinjectors hold dominant market share and is also the fastest growing segment in the market.

Application Analysis: Based on the application areas, the market is segmented into anaphylaxis, multiple sclerosis, rheumatoid arthritis, diabetes, and others. The market is dominated by anaphylaxis owing to a high prevalence rate globally. The fastest growing segment of the market is rheumatoid arthritis due to increased development of novel drugs for the treatment of the condition.

Topics Covered

1 Industry Outlook

2 Report Outline

3 Market Snapshot

4 Market Outlook

5 Market Characteristics

6 Application: Market Size & Analysis

7 Product Type: Market Size & Analysis

8 Regions: Market Size & Analysis

9 Competitive Landscape

10 Vendor Profiles

• AbbVie Inc
• Amgen Inc.
• Antares Pharma Inc.
• Bayer AG
• Becton Dickinson and Company
• Biogen Pharmaceuticals
• Eli Lilly & Company Ltd.
• Johnson & Johnson
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical
• Ypsomed Holding AG

For more information about this report visit https://www.researchandmarkets.com/research/tgj6b2/the_worldwide?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190121005187/en/